On 6 June, 2025, India decided to impose anti-dumping duties on vitamin A palmitate from China.
On 9 June, 2025, Er-Kang Pharma announced that the company's vitamin B6 injection has passed the generic consistency evaluation.
In June 2025, Northeast Pharmaceutical achieved an outstanding result of "zero deficiencies" by passing the three-day dietary supplement ingredient spot check conducted by the U.S. FDA.
Project Progress of Multiple Companies:
- Kangsu Bio's 1,000 t/a vitamin B6 project
- Brother Vitamin's 3,200 t/a vitamin B1 technical renovation project
- Beisheng Maoji's vitamin D3 oil project
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1869 on 3 June 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
